Discover the newest advancements in spasticity treatment, combining clinical studies, patient-centered approaches, and real-world data to enhance patient care and improve quality of life.
A recent critique highlights the need to consider vitreous adhesion angle alongside diameter in assessing vitreomacular traction (VMT), advocating for a more comprehensive diagnostic approach.
Spain's National Health System (SNS) is facing unprecedented challenges due to austerity policies. Explore the impact of these measures and the inspiring citizen resistance working to protect universal healthcare.
Discover how Canakinumab, a novel anti-IL-1β antibody, is transforming the treatment of acute gouty arthritis, especially for patients with chronic kidney disease and those who haven't responded to traditional therapies.
Discover the surprising connection between obesity, hormonal imbalances, and high blood pressure in teens born prematurely. Learn how these factors combine to elevate cardiovascular risks and what can be done.
Explore the vital role of kidney biopsies in ANCA-associated vasculitis, focusing on the impact of interstitial inflammation and T/B-cell presence on treatment outcomes and renal health.
Delve into the intricate world of oral and maxillofacial pathology through a curated collection of rare case studies. Discover the diagnostic challenges, treatment approaches, and essential follow-up care required for conditions like EBV-positive lymphomas, subgemmal neurogenous plaques, and aggressive juvenile ossifying fibromas. Learn how these cases underscore the importance of vigilance and expert evaluation in oral health.
Learn about the unique case of Pseudomonas fluorescens septic sacroiliitis in a healthy soldier, highlighting diagnostic challenges and successful oral antibiotic treatment.
For individuals grappling with chronic kidney disease (CKD), the intersection of kidney health and cardiovascular well-being is a critical concern. A groundbreaking study reveals how parathyroidectomy (PTX) can significantly enhance heart rate variability (HRV) in stage 5 CKD patients by targeting bone markers and curbing sympathetic hyperactivity.
In end-of-life care, the concept of 'clinical inertia'—deliberately choosing not to intervene—challenges conventional medical approaches. This article delves into the importance of this decision, emphasizing the balance between legal duties, patient wishes, and the emotional toll on healthcare providers.
